financetom
Business
financetom
/
Business
/
Market Chatter: Novartis, Roche Executives to Meet With Swiss Government About US Tariffs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Novartis, Roche Executives to Meet With Swiss Government About US Tariffs
Aug 11, 2025 11:57 AM

02:29 PM EDT, 08/11/2025 (MT Newswires) -- Novartis ( NVS ) and Roche executives are due to meet with Swiss government officials this week as President Donald Trump urges pharmaceutical firms to lower their prices in the US, Reuters reported Monday, citing two sources.

Economy Minister Guy Parmelin and Health Minister Elizabeth Baume-Schneider will meet with executives of the two drug makers as well as other companies, the sources told the news outlet.

Switzerland is aiming to negotiate with the US to lower the 39% tariffs announced on its exports, according to the report.

The discussions may also be about encouraging the drug makers to invest more in the US and reduce Switzerland's trade surplus with the country, which could help lower the tariffs, a source familiar with the matter told Reuters.

Novartis ( NVS ) and Roche did not immediately reply to requests for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 117.82, Change: +0.97, Percent Change: +0.83

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Former FDA vaccine chief Peter Marks joins Eli Lilly
Former FDA vaccine chief Peter Marks joins Eli Lilly
Oct 7, 2025
(Reuters) -Peter Marks, the former top vaccine regulator who was ousted from the U.S. Food and Drug Administration earlier this year, has joined Eli Lilly ( LLY ), the drugmaker told Reuters on Tuesday. Marks will oversee molecule discovery and infectious diseases at Lilly Research Laboratories. Peter's expertise strengthens our abilities across multiple areas, both in our existing portfolio and...
Sector Update: Consumer
Sector Update: Consumer
Oct 7, 2025
03:15 PM EDT, 10/07/2025 (MT Newswires) -- Consumer stocks were mixed late Tuesday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) increasing 0.6% and the Consumer Discretionary Select Sector SPDR Fund (XLY) retreating 1.7%. Redbook US same-store sales rose by 5.8% from a year earlier in the week ended Oct. 4 after a 5.9% year-over-year increase in the...
Former FDA vaccine chief Peter Marks joins Eli Lilly
Former FDA vaccine chief Peter Marks joins Eli Lilly
Oct 7, 2025
Oct 7 (Reuters) - Peter Marks, the former top vaccine regulator who was ousted from the U.S. Food and Drug Administration earlier this year, has joined Eli Lilly ( LLY ), the drugmaker told Reuters on Tuesday. Marks will oversee molecule discovery and infectious diseases at Lilly Research Laboratories. Peter's expertise strengthens our abilities across multiple areas, both in our...
ExchangeRight All-Cash 14 DST Fully Subscribed, Expanding Essential Income REIT Pipeline
ExchangeRight All-Cash 14 DST Fully Subscribed, Expanding Essential Income REIT Pipeline
Oct 7, 2025
PASADENA, Calif.--(BUSINESS WIRE)-- ExchangeRight has announced the full subscription of Net-Leased All-Cash 14 DST, adding to the growing acquisition pipeline for ExchangeRight’s Essential Income REIT. The $23.3 million debt-free portfolio of net-leased real estate, backed by tenants operating in necessity-based industries, provides investors with monthly distributions at a current rate of 5.20% covered entirely by in-place lease revenues. Net-Leased All-Cash...
Copyright 2023-2026 - www.financetom.com All Rights Reserved